共 50 条
- [31] The Relationship between EZH2 Expression and Renal Cell CarcinomaMODERN PATHOLOGY, 2012, 25 : 223A - 223ALee, H. W.Park, J. Y.Hwang, I.Jung, H. R.Kwon, S. Y.Kang, Y. N.Kim, S. P.Kwon, K.Lee, S. S.Choe, M. S.
- [32] Characterization Of The Effects Of Mutated EZH2 On Expression and Epigenome In a Mouse Lymphoma ModelBLOOD, 2013, 122 (21)Berg, TobiasThoene, SilviaYap, DamianWee, TraceeSchoeler, NathalieRosten, PattyLim, EmiliaBilenky, MishaMungall, Andrew J.Oellerich, ThomasUmlandt, PatriciaSalmi, AnisaChang, HarryYue, LisaLai, DavidCheng, GraceServe, HubertMorin, Ryan D.Hirst, MartinMarra, Marco A.Morin, Gregg B.Gascoyne, Randy D.Aparicio, Samuel A.Humphries, R. Keith
- [33] Prognostic outcomes of diffuse large B-cell lymphoma patients with myelocytomatosis oncogene (MYC) and B-cell lymphoma 2 (BCL2) co-expressionJournal of Hematopathology, 2025, 18 (1)Supanut KumjanKantang SatayasoontornKasidid LawongsaChonlada Laoruangroj
- [34] Analysis of EZH2 mutations and expression in monomorphic epitheliotrophic intestinal t-cell lymphoma (MEITL2)ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 317 - 317Weber, T.Rohde, C.Goellner, S.Nerger, K.Wehde, J.Wickenhauser, C.Fend, F.Hansmann, M. -LKlapper, W.Rosenwald, A.Stein, H.Mueller-Tidow, C.Mueller, L. P.
- [35] Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutationLEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2895 - 2901Zhou, ZhengGao, JuehuaPopovic, ReljaWolniak, KristyParimi, VamsiWinter, Jane N.Licht, Jonathan D.Chen, Yi-Hua
- [36] MYC stimulates EZH2 expression by repression of its negative regulator miR-26aBLOOD, 2008, 112 (10) : 4202 - 4212Sander, SandrineBullinger, LarsKlapproth, KayFiedler, KatjaKestler, Hans A.Barth, Thomas F. E.Moeller, PeterStilgenbauer, StephanPollack, Jonathan R.Wirth, Thomas
- [37] Analysis of c-MYC, EZH2, and Ki67 in Primary Diffuse Large B Cell Lymphoma of the Gastrointestinal TractAMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146Vafaii, PardisNguyen, JohnnyZhang, XiaohuiCoppola, DomenicoZhang, Ling
- [38] EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsNATURE, 2012, 492 (7427) : 108 - +McCabe, Michael T.Ott, Heidi M.Ganji, GopinathKorenchuk, SusanThompson, ChristineVan Aller, Glenn S.Liu, YanGraves, Alan P.Della Pietra, Anthony, IIIDiaz, ElsieLaFrance, Louis V.Mellinger, MarkDuquenne, CelineTian, XinrongKruger, Ryan G.McHugh, Charles F.Brandt, MartinMiller, William H.Dhanak, DashyantVerma, Sharad K.Tummino, Peter J.Creasy, Caretha L.
- [39] EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsNature, 2012, 492 : 108 - 112Michael T. McCabeHeidi M. OttGopinath GanjiSusan KorenchukChristine ThompsonGlenn S. Van AllerYan LiuAlan P. GravesAnthony Della Pietra IIIElsie DiazLouis V. LaFranceMark MellingerCeline DuquenneXinrong TianRyan G. KrugerCharles F. McHughMartin BrandtWilliam H. MillerDashyant DhanakSharad K. VermaPeter J. TumminoCaretha L. Creasy
- [40] Enhancer of Zeste Homolog 2 (EZH2) Is Widely Expressed in T-Cell Neoplasms and Correlates with MYC Expression in Most SubtypesMODERN PATHOLOGY, 2014, 27 : 378A - 379AShi, M.Shahsafaei, A.Yu, H.Dorfman, D. M.